The Hanover Insurance
Price chart
Anonymous reader poll. Unscientific, not investment advice.
✦ StockVane Quant Insights how this is computed
- Mid-pack momentum — held if you own it, not a fresh buy.
- Signal has read HOLD for 4 days.
- Recent price momentum is +23.4% on average (3-month/1-year).
- Main-fund capital flow has been a net inflow over the last 45 sessions.
- Short interest has risen to 2.7% of float.
- Analyst tilt is Buy.
- Price is below its 20-day average and above its 60-day average.
- The 20-day average is above the 60-day average, a short-term uptrend.
Computed by a StockVane algorithm from historical price, valuation and analyst data - not a person, not a forecast guarantee, and not investment advice.
Factor grades
Ranked against 2848 U.S. stocks StockVane covers.
Last computed: 2026-11-22 14:27 UTC
Data coverage: 6 of 6 factors. Missing data is not a zero score.
Valuation A-
How expensive the stock is versus earnings, sales and its own 5-year history.
| P/E (TTM) | 11.6x | Better than 72% |
| Forward P/E | 12.3x | Better than 66% |
| Price / Sales | 1.2x | Better than 72% |
| P/E vs own 5-yr range | 46th pctl | Better than 63% |
Growth A-
How fast revenue, profit and free cash flow are compounding.
| Revenue CAGR (3Y) | 6.5% | Better than 52% |
| Net income CAGR (3Y) | 78.7% | Better than 94% |
| Free cash flow CAGR (3Y) | 18.4% | Better than 63% |
Profitability B+
How much profit the business keeps from each dollar of sales and capital.
| Net margin | 10.1% | Better than 60% |
| Return on equity | 20.7% | Better than 79% |
Momentum A+
Recent price strength, skipping the latest month to avoid short-term noise.
| 3-month return | 9.4% | Better than 89% |
| 6-month return | 25.8% | Better than 87% |
| 12-month return (ex latest month) | 32.3% | Better than 71% |
| Distance below 52-week high | 5.3% | Better than 94% |
Financial Health A
Balance-sheet strength: leverage, liquidity and interest coverage.
| Debt to assets | 7.2% | Better than 75% |
| Interest coverage | 20.5x | Better than 83% |
| Free cash flow / net income | 176.7% | Better than 72% |
Analyst View D-
What the Street thinks: share of Buy ratings and upside to the average target.
| Analysts rating Buy | 28.6% | Better than 13% |
| Upside to average target | -0.3% | Better than 3% |
Grades are relative rankings, not forecasts: A+ is the top 5% of the covered stocks on a factor, F the bottom 3%. Valuation is not adjusted for sector. Background recomputation is scheduled every 6 hours; actual computation time is shown above, and source datasets have different reporting dates. Not investment advice or tailored to your financial situation.
Performance
Key statistics
Price & volume
- Prev close
- 242.99
- Open
- 245.97
- Day range
- 242.43 - 247.51
- Avg price
- 244.64
- Volume
- 204.22K
- Turnover
- 49.96M
- Turnover ratei
- 0.60%
- Volume ratioi
- 0.97
- Amplitudei
- 2.09%
- 52-week rangei
- 164.13 - 256.74
Valuation
- P/Ei
- 13.39
- P/E (TTM)i
- 11.64
- P/Bi
- 2.43
- EPSi
- 18.16
- Book value / shi
- 100.12
- Net profit
- 624.22M
- Net assets
- 3.44B
Share structure
- Market cap
- 8.36B
- Float capi
- 8.27B
- Shares out
- 34.37M
- Float sharesi
- 34.02M
Dividend & listing
- Div yield (TTM)i
- 1.56%
- Dividend (TTM)
- 3.80
- Listing date
- 1970-01-01
5.3% below the 52-week high
Trading activity
Net capital flow main funds, last 45 sessions
+1.09M net over the window
Short interest
- Shares short
- 937.68K
- % of floati
- 2.73%
- Days to coveri
- 3.17
- As of
- 2026-10-30
Frequently asked questions
What is the current stock price of The Hanover Insurance (THG)?
The Hanover Insurance last traded at 243.19. This page shows a periodic quote snapshot. Check the displayed quote time.
What is The Hanover Insurance's market cap?
About 8.36B.
What is the P/E ratio of The Hanover Insurance?
The trailing twelve-month P/E is 11.64. The Valuation tab shows it against the stock's own five-year range.
Does The Hanover Insurance pay a dividend?
Yes. The trailing dividend yield is 1.56%. The 2025 payout was up 5.8% from 2024. See the Dividends tab for the full payment history.
Is The Hanover Insurance a buy according to analysts?
The consensus of 7 analysts is a Buy rating, with an average 12-month price target of 242.43, which implies 0.3% downside from the current price. This is not investment advice.
What is The Hanover Insurance's StockVane Quant Rating?
The StockVane Momentum strategy currently rates The Hanover Insurance a C (Hold). Mid-pack momentum — held if you own it, not a fresh buy. Not investment advice.
Quote time 2026-11-20 19:30:06 · For reference only, not investment advice and not tailored to your situation.
The Hanover Insurance discussion 0 comments